Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3144481
Max Phase: Preclinical
Molecular Formula: C12H19N5O9P2
Molecular Weight: 439.26
Molecule Type: Small molecule
Associated Items:
ID: ALA3144481
Max Phase: Preclinical
Molecular Formula: C12H19N5O9P2
Molecular Weight: 439.26
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CN(C)c1ncnc2c1ncn2[C@H]1C[C@H](OP(=O)(O)O)[C@@H](COP(=O)(O)O)O1
Standard InChI: InChI=1S/C12H19N5O9P2/c1-16(2)11-10-12(14-5-13-11)17(6-15-10)9-3-7(26-28(21,22)23)8(25-9)4-24-27(18,19)20/h5-9H,3-4H2,1-2H3,(H2,18,19,20)(H2,21,22,23)/t7-,8+,9+/m0/s1
Standard InChI Key: TZNJXWNOXGZMDL-DJLDLDEBSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 439.26 | Molecular Weight (Monoisotopic): 439.0658 | AlogP: -0.23 | #Rotatable Bonds: 7 |
Polar Surface Area: 189.59 | Molecular Species: ACID | HBA: 10 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 14 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 0.49 | CX Basic pKa: 4.62 | CX LogP: -3.18 | CX LogD: -7.68 |
Aromatic Rings: 2 | Heavy Atoms: 28 | QED Weighted: 0.41 | Np Likeness Score: 0.45 |
1. Camaioni E, Boyer JL, Mohanram A, Harden TK, Jacobson KA.. (1998) Deoxyadenosine bisphosphate derivatives as potent antagonists at P2Y1 receptors., 41 (2): [PMID:9457242] [10.1021/jm970433l] |
Source(1):